Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Zero Minimum Robo Investing 2026 breaks down zero-entry robo options, focusing on costs, diversification, and automated rebalancing for beginners.
21,616 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
A fresh national analysis finds childcare costs far outpace income growth, forcing many families to rethink childrear...
A leading AI tool creator predicts a seismic shift in coding careers this year, with many engineers pivoting to produ...
TJX posted a strong fourth quarter ahead of expectations, yet conservative guidance sparked a pullback in shares as i...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
Traders chase BOIL as natural gas whipsaws drive outsized moves, despite heavy losses over the past year. The 2x leve...
XRP is testing a key technical juncture, with a weekly close above the 200 EMA and $1.55 potentially weakenting the b...
A new analysis challenges Dave Ramsey’s Social Security guidance, arguing that claiming at 62 can reduce lifetime ben...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
BNO has jumped about 52% year-to-date, yet roll costs and futures contango are quietly eroding its gains. Here's what...